Superbug resistance and synthesis of new pharmaceutical reagents
Resistance analysis of ESKAPE strains.. Methodology by A. Demchenko for C-level Pharma.
09Apr
Pharmacology
09Apr
03Apr
Epigenetic code and tetrapeptides in cell regulation
Analysis of the role of tetrapeptides in epigenetic regulation, telomeric biology, and modern translational biomedicine.
02Apr
Tetrapeptide regulation of gene expression and API synthesis
Scientific analysis of the interaction of tetrapeptides with the nucleosome apparatus. Technologies for the synthesis of high-purity API (>99.5%) according to the methodology of A....
14Mar
Gene therapy, telomerase, telomeres and tetrapeptides: is it possible to renew the telomere reserve?
The role of telomeres, telomerase, and gene therapy in controlling cellular aging. A simple explanation of complex biological processes.
12Mar
Gene Therapy Market: Opportunities, Barriers, and the Real Economy of the Industry
How the gene therapy market works, why it is growing, what is holding it back, and why it is one of the most complex segments...
11Mar
Gene therapy: how treatment works at the DNA level
What is gene therapy, how does it work, and why is it one of the major breakthroughs in modern pharmacology?
28Jan
Hybrid Sourcing in Pharmaceuticals: Risk Map 2026
Risk map 2026 for pharmaceutical procurement: hybrid sourcing, new API geography, stress nodes and alternative supply routes.
21Jan
The Low Price Trap: Why Cheap Procurement Will Kill Margins in 2026
Why the "buy cheaper" strategy no longer works in pharmaceuticals. An analysis of hidden costs, risks, and the new logic of margin management in 2026.
19Jan
Obesity as a chronic multifactorial disease
Obesity has long ceased to be just a consequence of an “unhealthy lifestyle.” Today, it is considered a chronic, relapsing disease.
16Jan
API Regulatory Geography: Risks and Control
How API regulatory geography is changing pharmaceutical procurement in 2026: FDA, EMA, GMP risks, new control areas and impact on TCO.
15Jan
AI in Pharma Procurement 2026: From Reactivity to Proactivity
As of early 2026, the concept of “procurement as a service” is finally a thing of the past. Our institute records a fundamental shift: procurement...
05Dec
Pharmacology of herbal medicines as a path from nature to evidence-based practice
In today's world, where environmental and social pressures are increasing, interest in natural healing systems is returning not as an "alternative", but as an equal...
04Dec
Green transformation of pharmacy combined with ecology
The modern pharmaceutical industry is undergoing a profound paradigm shift. The world is moving away from the “efficiency at any cost” model and towards a...
03Dec
Pharmacology of natural compounds as a potential for phytotherapy and natural extracts
Phytotherapy and the use of natural extracts from herbs, mushrooms, and plants is becoming increasingly popular among patients and practitioners. Natural compounds have a wide...
10Nov
Gene therapy and cell therapy: a breakthrough in the medicine of the future
In the world of modern medicine, we are on the verge of a real revolution. While genetic editing and cell cultivation seemed like fantasy a...
- 1
- 2
Documents
Patents
Popular articles
PROTECTING SOILS FROM ECOCIDE
The environmental consequences of armed aggression and...
Participation in the exhibition “Restoration of...
On November 6-7, 2024, the Institute took...
Investing in organic farming: market overview...
Organic farming has been gaining popularity in...
Benefits of organic farming for investors:...
Organic farming is becoming an increasingly attractive...
The second life of delicate human...
Among the well-known renewable energy sources, such...
Addressing the impact of heavy metals...
The war in Ukraine is causing catastrophic...